Literature DB >> 14264564

HETEROGENEITY OF ANTINUCLEAR FACTORS IN LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS.

E V BARNETT, R F BAKEMEIER, J P LEDDY, J H VAUGHAN.   

Abstract

Entities:  

Keywords:  ANTIBODIES; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, RHEUMATOID; FLUORESCENT ANTIBODY TECHNIC; GEL DIFFUSION TESTS; HEPATITIS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PSORIASIS

Mesh:

Substances:

Year:  1965        PMID: 14264564     DOI: 10.3181/00379727-118-29976

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


× No keyword cloud information.
  7 in total

1.  Classification of immunoglobulins in the dermo-epidermal junction in lupus erythematosus.

Authors:  R H Cormane; R E Ballieux; G L Kalsbeek; W Hymans
Journal:  Clin Exp Immunol       Date:  1966-04       Impact factor: 4.330

2.  Restrictions among heavy and light chain determinants of granulocyte-specific antinuclear factors.

Authors:  A Wiik; E Munthe
Journal:  Immunology       Date:  1972-07       Impact factor: 7.397

3.  Characterization of the gamma-globulin complexes present in certain sera having high titers of anti-gamma-globulin activity.

Authors:  R E Schrohenloher
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

4.  Immunofluorescent patterns and specificity of human antinuclear antibodies.

Authors:  Y B Bickel; E V Barnett; C M Pearson
Journal:  Clin Exp Immunol       Date:  1968-09       Impact factor: 4.330

5.  [Antinuclear antibodies in diagnosis of rheumatic diseases (author's transl)].

Authors:  K Helmke; R Scheuermann; T Boeder; M Oppermann; J Teuber; K Federlin
Journal:  Klin Wochenschr       Date:  1981-03-16

Review 6.  Antinuclear antibodies and nuclear antigens.

Authors:  E V Barnett
Journal:  Calif Med       Date:  1966-06

7.  The effect of azathioprine on gammaglobulin synthesis in man.

Authors:  J Levy; E V Barnett; N S MacDonald; J R Klinenberg; C M Pearson
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.